Nikko Asset Management Americas, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Nikko Asset Management Americas, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 02, 2020	SELL	$9.57 - $27.05 $5.59 Million - $15.8 Million	-583,657 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$7.14 - $31.69 $15.2 Million - $67.5 Million	-2,130,327 Reduced 78.49%	583,657 $13.9 Million
Q1 2020 Apr 30, 2020	SELL	$2.98 - $14.09 $6.95 Million - $32.9 Million	-2,333,624 Reduced 46.23%	2,713,984 $20.2 Million
Q4 2019 Feb 06, 2020	SELL	$1.97 - $3.72 $214,221 - $404,520	-108,742 Reduced 2.11%	5,047,608 $16.7 Million
Q3 2019 Oct 29, 2019	BUY	$2.05 - $3.02 $558,112 - $822,195	272,250 Added 5.57%	5,156,350 $10.6 Million
Q2 2019 Jul 29, 2019	BUY	$2.29 - $4.1 $3.71 Million - $6.65 Million	1,621,581 Added 49.7%	4,884,100 $14.4 Million
Q1 2019 Apr 30, 2019	BUY	$3.34 - $5.1 $10.9 Million - $16.6 Million	3,262,519 New	3,262,519 $12.2 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $521M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.